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Georgia Narsavage5, Maria Carmen Gomez6, Josep Roca1 and NEXES consortium
BACKGROUND: Chronic obstructive pulmonary disease (COPD) generates a high burden on health care, and hospital admissions
represent a substantial proportion of the overall costs of the disease. Integrated care (IC) has shown efﬁcacy to reduce
hospitalisations in COPD patients at a pilot level. Deployment strategies for IC services require assessment of effectiveness at the
health care system level.
AIMS: The aim of this study was to explore the effectiveness of a community-based IC service in preventing hospitalisations and
emergency department (ED) visits in stable frail COPD patients.
METHODS: From April to December 2005, 155 frail community-dwelling COPD patients were randomly allocated either to IC
(n= 76, age 73 (8) years, forced expiratory volume during the ﬁrst second, FEV1 41(19) % predicted) or usual care (n= 84, age 75(9)
years, FEV1 44 (20) % predicted) and followed up for 12 months. The IC intervention consisted of the following: (a) patient’s
empowerment for self-management; (b) an individualised care plan; (c) access to a call centre; and (d) coordination between the
levels of care. Thereafter, hospital admissions, ED visits and mortality were monitored for 6 years.
RESULTS: IC enhanced self-management (P= 0.02), reduced anxiety–depression (P= 0.001) and improved health-related quality of
life (P= 0.02). IC reduced both ED visits (P= 0.02) and mortality (P= 0.03) but not hospital admission. No differences between the
two groups were seen after 6 years.
CONCLUSION: The intervention improved clinical outcomes including survival and decreased the ED visits, but it did not reduce
hospital admissions. The study facilitated the identiﬁcation of two key requirements for adoption of IC services in the community:
appropriate risk stratiﬁcation of patients, and preparation of the community-based work force.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) has a high impact
on health care use and hospital admissions1,2 represent a marked
proportion of the overall costs of the disease.3–6 Age, co-
morbidities and previous history of multiple hospital admissions
are well identiﬁed as major frailty factors with a high risk for
unplanned admissions that are often associated with accelerated
disease progression.7,8
Conventional health care is too often oriented towards solving
acute events with a disease-oriented approach that has been
proven to be suboptimal for chronic patients.7,9 Consequently, the
deployment of effective and efﬁcient health care models for
patients with complex chronic conditions10 following an inte-
grated care (IC) approach11–13 is a widely accepted priority for
improving health systems. However, studies exploring long-term
outcomes and related factors that may limit extensive deployment
and sustainability of IC services are still needed.10,14–16
The literature on effectiveness of integrated disease manage-
ment in COPD patients displays controversial results. A recent
Cochrane review15 acknowledges high variability16 among well-
conceived randomised controlled trials (RCTs) on IC interventions,
but it concludes that IC shows positive outcomes in terms of
enhanced health-related quality of life, exercise capacity and
reduction of hospital requirements with no differences in mortality
rate. These results are consistent with a high potential for cost
reduction.17 However, there is a need for additional RCTs with
well-standardised interventions providing contextual information
on the characteristics of the health care systems wherein IC is
deployed to facilitate comparability among studies.
In a previously reported RCT using IC services for care of COPD
patients,18 an IC intervention run by hospital-based specialised
nurses reduced hospitalisations due to severe exacerbations by
40%. The patients were recruited from two tertiary hospitals
(Barcelona, Spain and Leuven, Belgium) immediately after
discharge for an exacerbation of their respiratory disease, with
no differences in health care outcomes between the two sites
despite the differences in the two national health care systems.
The principal objective of the current research was to assess the
effectiveness of the IC intervention18 in frail COPD patients
representative of a high-risk subset of patients in the population.
The main difference with Casas et al.18 was that the present study
delivered an IC service with a community-based approach using a
distributed model. That is, patients were recruited without
major restrictions regarding co-morbidities, and hospital-based
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respiratory nurse specialists played a supporting role to
community-based care professionals.
This study was aimed at analysing the potential for extensive
deployment of the previously reported IC intervention18 by
introducing ﬁve new elements: (a) clinically stable, albeit frail,
COPD patients selected from the community clinics rather than
recruited after hospital discharge; (b) a patient-centred inclusive
approach, with COPD as one diagnosis with higher severity and
more co-morbid conditions; (c) very low support by the
specialised team; (d) inclusion of community-based teams in the
IC intervention; and (e) two different providers. The IC intervention
was provided for 12 consecutive months, and then patients were
followed up passively for 6 additional years.
MATERIALS AND METHODS
Study group
The research was designed to explore the potential for generalisation of
the IC service reported by Casas et al.18 and provide relevant preliminary
information for the preparatory phase of the NEXES project (2008–13).11
The NEXES project has successfully explored strategies for extensive
deployment of four different types of IC services covering the entire
spectrum of severity of chronic patients. One of these four services was
enhanced care for frail chronic patients to prevent hospital admissions. The
current manuscript reports on the lessons learned for deployment of this
community-based IC service, following patients for 6 years beyond the
NEXES19,20 project.
A total of 155 clinically stable COPD patients with a history of at least
two hospital admissions owing to severe respiratory exacerbations during
two consecutive years were included in the NEXES study from April to
December 2005. At the time of the current study, 140 of these patients had
been managed under a conventional treatment regime (naïve patients),
and the remaining 15 had been enrolled in the hospital’s specialist nurse-
based enhanced care programme for COPD patients18 (Note that these 15
patients were statistically excluded in the ﬁnal analyses). The recruitment
was done using the records of our Institution (Hospital Clínic at Barcelona-
Esquerra). All patients signed the informed consent after full explanation of
the characteristics of the protocol. Ethics approval was granted by the
Ethical Committee of the Hospital Clinic.
In the selection process for the community-based study, we considered
a broad spectrum of COPD diagnostic terms that include chronic
obstructive inﬂammatory diseases namely, emphysema, asthma, tubercu-
losis, chronic bronchitis and COPD. Other inclusion criteria were aged
above 45 years and living at home within the health care area of the
hospital (Barcelona-Esquerra).
A total of 2,454 episodes of hospital admission corresponding to 860
chronic respiratory patients were identiﬁed using the inclusion criteria.
From this population, a person not involved in the study identiﬁed the
cases with COPD (ICD9-CM 491, 492, 493 or 496)21 as the primary diagnosis
for admission. Figure 1 displays the main exclusion criteria in the 160
patients eligible for the study. A computer-generated list of random
numbers with no restrictions and administered by personnel who were not
involved in the study ensured blinded randomisation (1:1 ratio); 76
patients were included in the community-based intervention group (IC)
and 84 in Usual Care (UC). The intervention was active over 12 months, and
the two groups were passively followed up for 6 additional years. Records
of the 155 patients who began the study and the 112 patients who
completed the 1-year follow-up were identiﬁed for review at 6 years.
Integrated care
The intervention included four key features. (1) A comprehensive
assessment of the patient at entry, including severity of the respiratory
disease, evaluation of co-morbid conditions and analysis of social support
needs, was completed.22 (2) A 2-h educational programme was
administered at entry by a respiratory nurse, followed by distribution of
patient-speciﬁc support material (www.separ.es).23 The educational
programme covered knowledge of the disease, instructions on non-
pharmacological treatment, administration techniques for proper pharma-
cological therapy and techniques for self-management of the disease and
co-morbid conditions including strategies to adopt with future exacerba-
tions. (3) One joint visit of the specialised nurse and the primary care team
(physician, nurse and social worker) at the patient home was completed
within 72 h after entry into the study. During this visit, the therapeutic plan
for each patient was customised to their individual frailty factors13,18,24,25
and shared with the primary care team. Reinforcement of the logistics for
treatment of co-morbidities and social support was done accordingly. (4)
Accessibility to the specialised nurse at the hospital was ensured for
primary care professionals during the follow-up period through an ICT
platform18,26–28 including a web-based call centre.
The community care teams received training: a 2-h face to face
educational training and 1-day stay at the hospital ward, aiming at
enhancing home-based management of frail COPD patients. The number
of home care visits during the 12-m follow-up period was individually
tailored to patient needs. Moreover, planned visits by respiratory
professionals were scheduled through the day hospital or home visits if
this was deemed necessary by primary care teams.
Usual care
Patients assigned to UC followed conventional treatment, being managed
by their physician without any support from specialised nurses. Visits were
usually scheduled every 6 months in the out-patient clinic.
Assessment
A blind evaluation of the study group carried out before randomisation
and after the 12-month follow-up consisted of a patient interview and
analysis of medical records, self-administered questionnaires and lung
function testing. The questionnaires were those used by Casas et al.18 with
additions designed to capture patient empowerment characteristics:
mental status,29 activities of daily living,30,31 anxiety and depression,32
health-related quality of life,33 Epworth sleepiness scale,34,35 6-min walking
test,36 nocturnal pulse oximetry and measurement of body mass
distribution using bioelectric impedance.37 Exacerbations requiring emer-
gency department (ED) consultations and/or hospital admissions within
the health care sector (Barcelona-Esquerra, 540.000 inhabitants) were
assessed using shared registries from the public health system. The
amount of potentially missed episodes of severe exacerbations owing to
the attendance of patients by private health care providers is negligible.
Six years after the end of the study, medical records and mortality were
reviewed in all patients.
Statistical analysis
Sample size calculation38 was obtained considering an IC:UC ratio of 1:1.
Estimating a proportion of 60% admitted in the UC group,18 accepting an
alpha risk of 0.05 and a beta risk of 0.20 in a two-sided test and anticipating
a drop-out rate of 0.15, a sample size of 73 patients per group was
necessary to recognise a statistically signiﬁcant relative risk of re-admission
of at least 0.70 in the IC versus the UC groups. This magnitude of effect is
lower than the relative risk of readmission (RR) (IC versus UC=0.55)
previously observed.18 The number of patients identiﬁed during the
screening process (n= 155) was higher than the 146 required, thus
ensuring enough statistical power.
Results are expressed as mean and s.d. or as number and percentages in
the corresponding categories. Comparisons between the two study groups
on admission and at 12 months were performed using unpaired Student's
t-test for continuous variables and Χ2-tests for non-continuous variables.
Changes within each group were assessed by paired analysis. The effects of
the intervention on the rate of admissions and mortality were analysed,
respectively, using multivariate logistic and Cox regression analysis,
adjusted for baseline differences between groups. Qualitative assessment
of technology was done using standard questionnaires and through focus
groups. As a sensitivity analysis, we repeated all analyses after excluding
patients who had a previous contact with any IC programme (n= 15).
Statistical signiﬁcance was set at a P value o0.05. Analyses were done
with STATA release 10.0 (2008, StataCorp LP, College Station, TX, USA).
RESULTS
Characteristics of the study group
At entry (Table 1, n= 155), the patients of the two groups showed
similar characteristics, except that inﬂuenza and pneumococcal
vaccination were more prevalent in the IC group (Po0.01).
Patients in both IC and UC groups were elderly, 14% were current
smokers deﬁned as ‘smoke every day or some days’ and 35% had
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an education level lower than primary school completion. It is
noteworthy that 55% were aware of the name of their COPD
disease, and 70% could identify an episode of exacerbation. The
average number of co-morbidities per patient was six. No
signiﬁcant differences between arms were observed in number
and categories of co-morbidities, previous history of emergency
room visits and hospital admissions.
As indicated in Figure 1, 25 patients (22%) died and 16 (14%)
were lost during the 1-year follow-up, and the remaining 114
patients (IC, n= 59 and UC, n= 55) completed the 12-month
assessment visit. Patients lost to follow-up exhibited a higher
affectation of activities of daily living and health-related quality of
life at baseline than those who were followed up, without
differences in other sociodemographic, clinical, functional and
medical care-related variables.
Effects after 12-month IC intervention
All 155 enrolled patients were included in this intention-to-treat
analysis. After adjusting for baseline differences, the IC arm
strongly reduced both the risk of emergency room visits (P= 0.02)
and mortality (P= 0.03), as displayed in Table 2. No differences
between arms were observed in admissions neither owing to
respiratory cause nor to other causes. However, the IC intervention
markedly changed the pattern of hospitalisations. Eighty percent
of the admissions in the IC arm were coordinated (planned)
between primary care and the hospital team, thus not using the
ED. By contrast, all admissions (100%) in the UC arm were
processed as unplanned hospitalisations through the ED (P value
not computable).
As secondary outcomes, we compared the ﬁnal characteristics
of 114 patients followed up with 12 months between intervention
and UC groups. Patients in the IC arm showed a lower percentage
of current smokers (UC, 16% vs. ICS, 3%, P= 0.02), better COPD
knowledge and self-management (50% vs. 71%, P= 0.02), lower
depression score (Anxiety and Depression Scale, HADS)32 (mean 7
vs. 5, Po0.01) and fewer symptoms score in the St George's
Respiratory Questionnaire (mean 42 vs. 32, P= 0.02) than in the UC
arm (Table 3).
After the study, patients in the intervention group returned to
UC. The assessment carried out after 6 years of passive follow-up
did not show any signiﬁcant difference between the two arms in
mortality or hospital admissions. It was not possible to identify the
role of planned versus unplanned admissions from the records.
Figure 1. Flowchart of the study.
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DISCUSSION
Main ﬁndings
In the current research, we observed that the community-based IC
approach signiﬁcantly enhanced survival in the intervention arm.
To our understanding, the study generated three well-deﬁned
lessons learned with a high potential for generalisation.
First, a standardised intervention with a holistic approach based
on shared agreements across levels of care markedly decreased
emergency room visits and completely changed the usual proﬁle
of unplanned admissions7 towards planned hospitalisations over 1
year of active IC management and coordination. However, after 6
years, no differences between the two groups were seen, which
suggests that the approach was not adequately adopted at the
community level and thus the intervention was not continued.
Second, after the 1-year follow-up, the treatment group
presented evidence of a healthier lifestyle, improved self-
management and higher health-related quality of life than the
control group. All these achievements were speciﬁc to the IC
intervention group and are consistent with the signiﬁcant
decrease in mortality rate observed in the intervention group.
The third was a not less important consideration. Despite the
similarities of this study outcome with those of the IC intervention
by Casas et al.,18 we were not able to reduce hospital admissions
and/or mean hospital stay over time. Among the differences
between the two studies, signiﬁcant factors to be taken into
consideration in the interpretation of the longitudinal results is the
fact that the role of the specialised team, by study design, was to
provide support to the community team at demand. In other
words, although the Casas et al. study18 showed the typical
characteristics of a pilot approach wherein a hospital-based
specialised nurse takes direct care of all the elements of the
intervention, the current investigation is closer to deployment of
community-based IC run by primary care professionals.
Interpretation of ﬁndings in relation to previously published work
As inidcated in the Introduction, the literature on effectiveness of
integrated disease management in COPD patients displays
controversial results. The current research suggests that the
organisational component, i.e., the management of the change
Table 2. Effects of the integrated care intervention, compared with
usual care, in 155 frail COPD patients
ORa (95% CI) P values
Hospital admissions owing to COPD
exacerbations
2.17 (0.60–7.87) 0.237
Emergency room admissions owing to
COPD exacerbations
0.33 (0.13–0.84) 0.020
HRa (95% CI)
All-cause mortality 0.36 (0.14–0.93) 0.034
Abbreviations: CI, conﬁdence interval; COPD, chronic obstructive pulmon-
ary disease; OR, odds ratio.
aAdjusted for baseline differences between usual care and integrated care
group (inﬂuenza and pneumococcal vaccination).
Table 3. Comparison between UC and IC at the end of the 12-month
follow-up
UC, n= 55 IC, n=59 P values
Active smokers, n (%) 9 (16) 2 (3) 0.02
MRC dyspnoea scale, mean (s.d.) 2.4 (1.3) 2.4 (1.2) 0.96
Lawton index (0–8), mean (s.d.) 6.2 (0.9) 6.3 (0.8) 0.26
HADS (0–15)
Anxiety, mean (s.d.) 7 (4) 5 (4) 0.13
Depression, mean (s.d.) 7 (5) 5 (3) o0.01
Quality of life (SGRQ), mean (s.d.)
Total score (0–100) 49 (22) 43 (20) 0.13
Symptoms score (0–100) 42 (24) 32 (20) 0.02
Activity score (0–100) 69 (24) 63 (26) 0.20
Impacts score (0–100) 40 (24) 36 (21) 0.28
Inﬂuenza vaccination, n (%) 47 (86) 57 (98) 0.01
Pneumococcal vaccination, n (%) 28 (70) 49 (89) 0.02
LTOT, n (%) 28 (51) 39 (66) 0.10
Long-acting β2-agonists, n (%) 20 (36) 10 (17) 0.02
Anticholinergics, n (%) 49 (89) 56 (95) 0.25
Inhaled steroids, n (%) 50 (60) 53 (70) 0.18
COPD knowledge and self-
management, n (%)
25 (50) 40 (71) 0.02
Abbreviations: COPD, chronic obstructive pulmonary disease; HADS,
Hospital Anxiety/Depression Scale; IC, integrated care; LTOT, long-term
oxygen therapy; MRC, Medical Modiﬁed Research Council Scale for scoring
dyspnoea; SGRQ, Saint George’s Respiratory Questionnaire to assess
health-related quality of life; UC, usual care.
Results are expressed either as mean± s.d. or as number (percentage) of
subjects in the corresponding category.
Table 1. Baseline characteristics of the study groups
UC, n=84 IC, n= 71 P values
Sociodemographics
Age (years), mean (s.d.) 75 (9) 73 (8) 0.21
Gender (female), n (%) 12 (14) 12 (17) 0.65
Active smokers, n (%) 12 (14) 9 (13) 0.77
Clinical and functional proﬁles, mean (s.d.)
FVC (% pred) 67 (20) 62 (19) 0.11
FEV1 (% pred) 44 (20) 41 (19) 0.27
FEV1/ FVC (%) 0.47 (0.15) 0.47 (0.13) 0.96
PaO2 (mmHg) 68 (13) 69 (10) 0.93
PaCO2 (mmHg) 40 (8) 41 (19) 0.69
BMI (kg/m2) 27 (5) 29 (5) 0.12
MRC dyspnoea scale 2.5 (1.3) 2.7 (1.3) 0.38
6MWT ( m) 357 (82) 355 (103) 0.93
Co-morbidities 6 (3) 6 (3) 0.98
Mini-mental scale (MEC; 0–35) 29 (4) 30 (4) 0.06
Lawton Index (0–8) 4.4 (2) 5 (2) 0.50
HADS (0–15)
Anxiety 6 (5) 6 (4) 0.23
Depression 6 (5) 6 (4) 0.30
Quality of life (SGRQ), total score
(0–100)
49 (21) 47 (19) 0.47
Number of previous admissions 1.7 (1.2) 1.8 (1.0) 0.61
COPD treatment, n (%)
Inﬂuenza vaccination 68 (81) 66 (94) 0.01
Pneumococal vaccination 40 (55) 48 (75) 0.01
LTOT 32 (39) 30 (43) 0.64
Long-acting β2-agonists 32 (39) 22 (31) 0.30
Anticholinergics 78 (95) 66 (93) 0.57
Inhaled glucocorticosteroids 63 (75) 58 (82) 0.32
Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmon-
ary disease; FEV1, forced expiratory volume during the ﬁrst second; FVC,
forced vital capacity; HADS, Hospital Anxiety/Depression Scale; IC,
integrated care; Lawton Index, performance in activities of daily living;
LTOT, long-term oxygen therapy; MEC, mental status; MRC, Medical
Modiﬁed Research Council Scale for scoring dyspnoea; 6MWT, 6- min
walking distance; PaO2 and PaCO2, partial pressure of oxygen and carbon
dioxide, respectively, breathing room air; SGRQ, Saint George’s Respiratory
Questionnaire to assess health-related quality of life; UC, usual care.
Results are expressed either as mean± s.d. or as number (percentage) of
subjects in the corresponding category.
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and, in particular, the preparation of the workforce, emerges as
one of the most relevant factors required to ensure successful
scalability of this type of IC intervention at a regional level.10,39–46
We acknowledge, however, that other differential factors might
limit the comparability between the two studies. An additional
limiting factor for the current study compared with Casas et al.18
as a disease-oriented approach involving stronger exclusion
criterion, whereas the current investigation included patients with
a higher number of more severe co-morbid conditions, a strategy
better aligned with real-world patient-centred care.
Regarding the potential impact of frailty, multiple studies7,8,47
clearly indicate that age and co-morbidities are two of the main
factors contributing to the patient’s frailty and modulating an
individual’s risk proﬁle. As indicated above, patients in the current
study presented these two factors (mean age 74 years and a mean
of six co-morbidities), which, in turn, may explain the history of
previous admissions despite the fact that our patients only had
moderate to severe chronic respiratory disease (mean forced
expiratory volume during the ﬁrst second 42% predicted). Other
determinants of patient’s frailty are anxiety–depression and
fragmentation of care7 that can ultimately lead to lower health-
related quality of life with an enormous use of resources and poor
prognosis. The lack of an operational deﬁnition of frailty48 and
complexity for COPD patients can be seen as a pivotal limiting
element precluding the association of speciﬁc shared-care
agreements with patient stratiﬁcation based on frailty proﬁles.
In summary, two key components for addressing the complex-
ities of care include (i) appropriate health risk assessment49 (case
ﬁnding) and subsequent patient stratiﬁcation and (ii) efﬁcient
workﬂow designs across levels of care including IC services with
shared-care agreements between specialised and primary care
including social support.10 The difﬁculties of managing the
complex care of our patients with multiple chronic conditions
can be seen in the (unjustiﬁed) scepticism raised by some studies
on the role of IC services in COPD patients.3
Strengths and limitations of this study
The manuscript reports data collected in a RCT enriched by the
lessons learned during the NEXES lifespan, which, we believe,
highly strengthen the conclusions. However, we identiﬁed two
major issues that could be interpreted as weaknesses of the
report. First, although the study was ofﬁcially registered as part of
the EU Grant (CIP-ICT-PSP-2007.225025), the RCT was not included
in the clinicaltrials.gov registry because at that time it was not
compulsory. The second limitation is the long delay between data
collection and reporting, which can be justiﬁed by the fact that the
current manuscript uses preparatory data to support lessons learnt
throughout the project over a 6-year longitudinal record review.
Implications for future research, policy and practice
The study raises two core issues for the deployment and adoption
of community-based IC. The role of change management and
workforce preparation are crucial to institutionalisation of a
system change. Another challenge is to address, in a dynamic
manner, the interplay between population-based stratiﬁcation for
case ﬁnding and individualised risk prediction to support health
professionals in the decision-making process. There is a clear need
to successfully impact both challenges in order to succeed in
providing personalised care for chronic patients within an IC
system.
Conclusions
The community-based IC intervention generated positive
clinical outcomes in terms of mortality, ED admissions and
self-management of COPD patients, but not hospital admissions.
However, we conclude that further progress in (a) operational
strategies to deal with frailty at individual level and (b) workforce
preparation are priority issues that are needed for extensive
deployment of the chronic care model. The present study
provides insights into unmet needs of a coordinated care
approach for the management of frail COPD patients with multi-
morbidities.
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